News about "Pharmaceutical Manufacturing"

PharmAla Completes GMP Manufacturing for ALA-002

PharmAla Completes GMP Manufacturing for ALA-002

PharmAla has completed GMP manufacturing of ALA-002 drug substance components and is preparing to begin GMP drug product manufacturing for upcoming global clinical trials.

Pharmaceutical Manufacturing | 07/07/2026 | By News Bureau

Shantha Biologics Announces Strategic Cartridge Fill-Finish Collaboration

Shantha Biologics Announces Strategic Cartridge Fill-Finish Collaboration

Shantha Biologics has announced a cartridge fill-finish collaboration with Novo Nordisk, strengthening high-quality biologics manufacturing and global healthcare partnerships.

Pharmaceutical Manufacturing | 04/07/2026 | By News Bureau

Morepen Begins Commercial Supplies under INR 825 Crore CDMO Contract

Morepen Begins Commercial Supplies under INR 825 Crore CDMO Contract

Morepen has started commercial supplies under its INR 825 crore CDMO mandate, completing the first INR 50 crore dispatch in Q1 FY2026-27 and strengthening its contract manufacturing business.

Pharmaceutical Manufacturing | 01/07/2026 | By News Bureau

Advanta bioKEMIX Forms Joint Venture with Resolkem to Expand High-Purity Solvent Manufacturing

Advanta bioKEMIX Forms Joint Venture with Resolkem to Expand High-Purity Solvent Manufacturing

Resolkem aims to combine advanced manufacturing capabilities with global market access to strengthen supply chains for pharmaceutical, biotechnology and specialty chemical industries.

Pharmaceutical Manufacturing | 25/06/2026 | By News Bureau

CDSCO Clarifies Regulatory Pathway for Formulation Intermediates, Mandates Approval for Modified-Release Drug Components

CDSCO Clarifies Regulatory Pathway for Formulation Intermediates, Mandates Approval for Modified-Release Drug Components

The Central Drugs Standard Control Organisation (CDSCO) has clarified the regulatory framework for formulation intermediates, specifying which products require central approval under the NDCT Rules, 2019 and which can be licensed by State Licensing Authorities (SLAs).

Pharmaceutical Manufacturing | 25/06/2026 | By News Bureau

US FDA Classifies Aurobindo Pharma's Eugia Unit-III Inspection as Official Action Indicated

US FDA Classifies Aurobindo Pharma's Eugia Unit-III Inspection as Official Action Indicated

Aurobindo Pharma said the US FDA has classified its inspection of Eugia Unit-III in Telangana as Official Action Indicated, while reaffirming its commitment to maintaining global quality manufacturing standards.

Pharmaceutical Manufacturing | 16/06/2026 | By News Bureau 155

Akums Secures European CEP Approval for Cefpodoxime Proxetil API

Akums Secures European CEP Approval for Cefpodoxime Proxetil API

Akums Drugs and Pharmaceuticals has received a Certificate of Suitability from the EDQM for its Cefpodoxime Proxetil API, reinforcing the company’s commitment to global quality compliance and enhancing its position as a trusted manufacturing partner for regulated international markets.

Pharmaceutical Manufacturing | 06/06/2026 | By News Bureau

Indoco Remedies Secures EU GMP Certification for Baddi Formulation Plant III

Indoco Remedies Secures EU GMP Certification for Baddi Formulation Plant III

Indoco Remedies has received EU GMP certification for its Baddi Plant III formulation facility following a successful inspection conducted in April 2026.

Pharmaceutical Manufacturing | 28/05/2026 | By News Bureau 132

DuPont Launches Liveo Pharma TPE Overmolded Assemblies for Biopharma Processing

DuPont Launches Liveo Pharma TPE Overmolded Assemblies for Biopharma Processing

DuPont introduces advanced TPE overmolded assemblies to enable safer, more efficient ultrapure fluid transfer in biopharmaceutical manufacturing, reducing contamination risks and operational complexity.

Pharmaceutical Manufacturing | 23/04/2026 | By News Bureau 111

Health Minister JP Nadda Unveils 10th Indian Pharmacopoeia

Health Minister JP Nadda Unveils 10th Indian Pharmacopoeia

The Union Health Minister highlighted the Indian Pharmacopoeia’s recognition in 19 Global South countries, India’s rise to eighth globally in WHO pharmacovigilance, and key updates in IP 2026, including 121 new monographs and the first inclusion of blood component standards.

Pharmaceutical Manufacturing | 02/01/2026 | By News Bureau 281


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members